🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 11 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/12/2016 | 65,17 | 67,10 | 64,43 | 65,18 | +0,82% | 4,10% | 444.993 |
| 08/12/2016 | 63,88 | 64,68 | 62,54 | 64,65 | +1,01% | 3,35% | 402.674 |
| 07/12/2016 | 65,37 | 65,37 | 62,13 | 64,00 | -3,10% | 4,95% | 526.425 |
| 06/12/2016 | 66,38 | 66,91 | 65,25 | 66,04 | -0,60% | 2,50% | 479.778 |
| 05/12/2016 | 65,27 | 67,85 | 65,01 | 66,44 | +2,30% | 4,36% | 480.259 |
| 02/12/2016 | 64,32 | 65,93 | 63,72 | 64,95 | +0,61% | 3,42% | 310.982 |
| 01/12/2016 | 65,57 | 65,57 | 63,64 | 64,56 | -0,87% | 2,95% | 588.782 |
| 30/11/2016 | 66,28 | 66,58 | 64,65 | 65,13 | -0,91% | 2,91% | 432.650 |
| 29/11/2016 | 65,32 | 66,61 | 64,58 | 65,73 | +0,43% | 3,10% | 389.689 |
| 28/11/2016 | 66,19 | 66,31 | 64,70 | 65,45 | -1,74% | 2,42% | 521.777 |
| 25/11/2016 | 67,05 | 67,05 | 65,50 | 66,61 | -0,06% | 2,31% | 230.992 |
| 23/11/2016 | 64,28 | 66,76 | 63,72 | 66,64 | +0,04% | 4,73% | 802.943 |
| 22/11/2016 | 67,18 | 67,26 | 65,76 | 66,62 | -0,48% | 2,24% | 432.650 |
| 21/11/2016 | 65,85 | 67,06 | 65,49 | 66,94 | +1,48% | 2,39% | 397.384 |
| 18/11/2016 | 66,14 | 66,23 | 65,13 | 65,97 | +0,20% | 1,66% | 346.569 |
| 17/11/2016 | 65,25 | 66,21 | 64,54 | 65,84 | +1,63% | 2,56% | 443.871 |
| 16/11/2016 | 65,62 | 66,47 | 64,66 | 64,78 | -2,19% | 2,76% | 522.738 |
| 15/11/2016 | 68,08 | 68,43 | 64,57 | 66,24 | -2,99% | 5,68% | 695.702 |
| 14/11/2016 | 67,36 | 69,14 | 65,75 | 68,28 | +2,43% | 5,03% | 668.291 |
| 11/11/2016 | 65,73 | 66,96 | 65,09 | 66,66 | +1,18% | 2,85% | 885.658 |
| 10/11/2016 | 66,12 | 67,37 | 64,67 | 65,88 | +0,79% | 4,09% | 860.010 |
| 09/11/2016 | 59,86 | 65,86 | 59,66 | 65,36 | +8,17% | 10,35% | 1.515.476 |
| 08/11/2016 | 58,05 | 60,64 | 57,46 | 60,42 | +3,14% | 5,48% | 678.710 |
| 07/11/2016 | 57,88 | 58,88 | 56,99 | 58,58 | +2,76% | 3,27% | 722.152 |
| 04/11/2016 | 54,90 | 60,51 | 54,59 | 57,01 | +0,25% | 10,80% | 1.256.431 |
| 03/11/2016 | 59,00 | 59,08 | 56,28 | 56,87 | -2,97% | 4,76% | 832.759 |
| 02/11/2016 | 59,60 | 59,99 | 58,55 | 58,61 | -2,10% | 2,41% | 309.379 |
| 01/11/2016 | 59,90 | 60,16 | 58,53 | 59,87 | +0,25% | 2,72% | 280.365 |
| 31/10/2016 | 59,30 | 60,42 | 58,65 | 59,72 | +0,68% | 2,99% | 389.369 |
| 28/10/2016 | 57,94 | 59,98 | 57,03 | 59,31 | +1,86% | 5,08% | 475.450 |